1. Home
  2. IIPR vs ARDX Comparison

IIPR vs ARDX Comparison

Compare IIPR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Industrial Properties Inc.

IIPR

Innovative Industrial Properties Inc.

HOLD

Current Price

$46.18

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.77

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IIPR
ARDX
Founded
2016
2007
Country
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IIPR
ARDX
Price
$46.18
$6.77
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$74.67
$12.95
AVG Volume (30 Days)
219.1K
3.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
16.43%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$22.44
Revenue Next Year
$1.70
$34.00
P/E Ratio
$10.92
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.58
$3.50
52 Week High
$74.92
$8.40

Technical Indicators

Market Signals
Indicator
IIPR
ARDX
Relative Strength Index (RSI) 37.66 41.88
Support Level $45.20 $6.92
Resistance Level $46.56 $7.43
Average True Range (ATR) 1.16 0.31
MACD -0.16 -0.15
Stochastic Oscillator 26.35 9.51

Price Performance

Historical Comparison
IIPR
ARDX

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: